59 U.S. lawmakers have disclosed 231 Pfizer Inc. trades under the STOCK Act — 107 buys and 124 sells between 2012 and 2026. Congress has been net sellers of PFE, and their disclosed buys are down 3.3% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of PFE, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed PFE buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2018-11-12 | David A Perdue , Jr | SELL | $1K–$15K | $41.85 | $26.80 2026-08-13 | +34.7% rt |
| 2018-11-09 | David A Perdue , Jr | SELL | $1K–$15K | $42.01 | $26.80 2026-08-13 | +35.8% rt |
| 2018-11-08 | David A Perdue , Jr | SELL | $1K–$15K | $41.60 | $26.80 2026-08-13 | +34.5% rt |
| 2018-11-05 | David A Perdue , Jr | SELL | $15K–$50K | $41.29 | $26.80 2026-08-13 | +34.5% rt |
| 2018-11-02 | David A Perdue , Jr | SELL | $1K–$15K | $40.73 | $26.80 2026-08-13 | +32.7% rt |
| 2018-11-01 | David A Perdue , Jr | SELL | $1K–$15K | $41.43 | $26.80 2026-08-13 | +34.9% rt |
| 2018-10-31 | David A Perdue , Jr | SELL | $15K–$50K | $40.85 | $26.80 2026-08-13 | +33.0% rt |
| 2018-10-30 | David A Perdue , Jr | SELL | $1K–$15K | $40.69 | $26.80 2026-08-13 | +33.5% rt |
| 2018-10-29 | David A Perdue , Jr | SELL | $15K–$50K | $41.02 | $26.80 2026-08-13 | +34.5% rt |
| 2018-10-12 | David A Perdue , Jr | SELL | $1K–$15K | $41.54 | $26.80 2026-08-13 | +36.5% rt |
| 2018-10-02 | David A Perdue , Jr | SELL | $1K–$15K | $41.95 | $26.80 2026-08-13 | +37.8% rt |
| 2018-09-19 | James B. Renacci | BUY | $1K–$15K | $41.04 | $26.80 2026-08-13 | -34.7% |
| 2018-09-13 | Kurt Schrader | BUY | $1K–$15K | $40.65 | $26.80 2026-08-13 | -34.1% |
| 2018-09-05 | David P. Roe | BUY | $1K–$15K | $39.71 | $26.80 2026-08-13 | -32.5% |
| 2018-08-17 | Dwight Evans | BUY | $1K–$15K | $39.93 | $26.80 2026-08-13 | -32.9% |
| 2018-08-08 | David A Perdue , Jr | SELL | $1K–$15K | $39.29 | $26.80 2026-08-13 | +28.5% rt |
| 2018-08-03 | David P. Roe | BUY | $1K–$15K | $38.46 | $26.80 2026-08-13 | -30.3% |
| 2018-06-28 | Kenny Marchant | SELL | $1K–$15K | $34.50 | $26.80 2026-08-13 | +15.7% rt |
| 2018-06-12 | Kenny Marchant | BUY | $1K–$15K | $34.44 | $26.80 2026-08-13 | -22.2% |
| 2018-06-04 | Susan M Collins | SELL | $1K–$15K | $34.58 | $26.80 2026-08-13 | +22.5% exit |
| 2018-05-04 | Earl Blumenauer | BUY | $1K–$15K | $33.05 | $26.80 2026-08-13 | -18.9% |
| 2018-02-28 | Earl Blumenauer | BUY | $1K–$15K | $34.45 | $26.80 2026-08-13 | -22.2% |
| 2018-02-26 | K. Michael Conaway | SELL | $1K–$15K | $35.19 | $26.80 2026-08-13 | +23.8% exit |
| 2018-02-23 | David A Perdue , Jr | SELL | $1K–$15K | $34.40 | $26.80 2026-08-13 | +12.5% rt |
| 2018-02-08 | Virginia Foxx | SELL | $50K–$100K | $31.91 | $26.80 2026-08-13 | +9.7% rt |
| 2017-10-25 | Lois Frankel | SELL | $1K–$15K | $34.31 | $26.80 2026-08-13 | +7.7% rt |
| 2017-09-06 | James B. Renacci | BUY | $1K–$15K | $32.25 | $26.80 2026-08-13 | -16.9% |
| 2017-09-05 | Shelley M Capito | BUY | $1K–$15K | $32.07 | $26.80 2026-08-13 | -16.4% |
| 2017-08-04 | Linda T. Sanchez | SELL | $1K–$15K | $31.92 | $26.80 2026-08-13 | +16.0% exit |
| 2017-08-01 | Virginia Foxx | BUY | $15K–$50K | $31.39 | $26.80 2026-08-13 | -14.6% |
| 2017-07-19 | Lois Frankel | BUY | $1K–$15K | $31.90 | $26.80 2026-08-13 | -16.0% |
| 2017-06-15 | Patty Murray | SELL | $1K–$15K | $31.13 | $26.80 2026-08-13 | -4.7% rt |
| 2017-06-12 | John A. Yarmuth | BUY | $1K–$15K | $31.02 | $26.80 2026-08-13 | -13.6% |
| 2017-05-17 | David A Perdue , Jr | BUY | $1K–$15K | $30.58 | $26.80 2026-08-13 | -12.4% |
| 2017-03-16 | Patty Murray | BUY | $1K–$15K | $32.67 | $26.80 2026-08-13 | -18.0% |
| 2017-03-13 | Mike Kelly | BUY | $1K–$15K | $32.36 | $26.80 2026-08-13 | -17.2% |
| 2017-03-02 | David A Perdue , Jr | BUY | $1K–$15K | $32.74 | $26.80 2026-08-13 | -18.1% |
| 2017-02-27 | David A Perdue , Jr | BUY | $1K–$15K | $32.52 | $26.80 2026-08-13 | -17.6% |
| 2017-02-27 | David A Perdue , Jr | BUY | $1K–$15K | $32.52 | $26.80 2026-08-13 | -17.6% |
| 2017-02-22 | David A Perdue , Jr | BUY | $15K–$50K | $31.87 | $26.80 2026-08-13 | -15.9% |
| 2017-02-22 | Lois Frankel | BUY | $1K–$15K | $31.87 | $26.80 2026-08-13 | -15.9% |
| 2017-02-22 | David A Perdue , Jr | BUY | $15K–$50K | $31.87 | $26.80 2026-08-13 | -15.9% |
| 2017-02-17 | David A Perdue , Jr | BUY | $1K–$15K | $31.90 | $26.80 2026-08-13 | -16.0% |
| 2017-02-17 | David A Perdue , Jr | BUY | $1K–$15K | $31.90 | $26.80 2026-08-13 | -16.0% |
| 2017-02-16 | David A Perdue , Jr | BUY | $1K–$15K | $31.90 | $26.80 2026-08-13 | -16.0% |
| 2017-02-16 | David A Perdue , Jr | BUY | $1K–$15K | $31.90 | $26.80 2026-08-13 | -16.0% |
| 2017-02-14 | David A Perdue , Jr | BUY | $1K–$15K | $31.07 | $26.80 2026-08-13 | -13.8% |
| 2017-02-14 | Kathy Castor | SELL | $1K–$15K | $31.07 | $26.80 2026-08-13 | +11.6% rt |
| 2017-02-14 | David A Perdue , Jr | BUY | $1K–$15K | $31.07 | $26.80 2026-08-13 | -13.8% |
| 2017-02-13 | David A Perdue , Jr | BUY | $1K–$15K | $30.94 | $26.80 2026-08-13 | -13.4% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
59 members of the U.S. House and Senate have disclosed Pfizer Inc. transactions under the STOCK Act — 107 purchases and 124 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a PFE purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed PFE buys are down 3.3% versus the latest close of $26.80. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded PFE and how it performed.